Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T22:04:43.455Z.
Consensus retrieved: 2026-10-06T17:56:54.709Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T22:04:43.455Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: aebbac3c8f5cd71f6a0736116a7e77570b12e82b9576f853dd4f644618eebaf7
Forward PE Ratio (N/A) = Dated Quote Price ($30.03) / Consensus Forward EPS ($-1.41)
FORWARD PE RATIO
N/A
vTv Therapeutics Inc.
Market Cap
$78.59M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| vTv Therapeutics Inc. (VTVT) | $78.59M | N/A |
| Sera Prognostics, Inc. (SERA)vs › | $78.29M | N/A |
| Citius Oncology, Inc. (CTOR)vs › | $79.03M | 8.50 |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $78.07M | N/A |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $79.61M | N/A |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $77.54M | N/A |
| Humacyte, Inc. (HUMA)vs › | $80.30M | N/A |
| Outset Medical, Inc. (OM)vs › | $76.74M | N/A |
| Nutriband Inc. (NTRB)vs › | $81.20M | 4.25 |
| MediciNova, Inc. (MNOV)vs › | $81.22M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $30.03, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-1.41 | $-2.86 – $-0.58 | 4 | n/m |
| 2027-12-31 | $-4.43 | $-6.24 – $-2.55 | 4 | n/m |
| 2028-12-31 | $-4.77 | $-6.61 – $-3.71 | 5 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
